TRITON and Beyond: New Insights into the Profile of Prasugrel-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TRITON and Beyond: New Insights into the Profile of Prasugrel

Published:2011-02-17 Issue:4 Volume:30 Page:e174-e182
ISSN:1755-5914
Container-title:Cardiovascular Therapeutics
language:en
Short-container-title:Cardiovasc Ther

Author:

Jakubowski Joseph A.,Riesmeyer Jeffrey S.,Close Sandra L.,Leishman Amy G.,Erlinge David

Publisher

Wiley

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-5922.2011.00263.x/fullpdf

Reference86 articles.

1. Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity;Niitsu;Semin Thromb Haemost,2005

2. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease;Jernberg;Eur Heart J,2006

3. The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel's active metabolite;Sugidachi;J Thromb Haemost,2007

4. Prasugrel: A novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical development;Angiolillo;Expert Opin Pharmacother,2008

5. Prasugrel: A novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basic for its distinct antiplatelet profile;Jakubowski;Cardiovasc Drug Rev,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P2Y12 Antagonists;Platelets;2019

2. Low body weight and clinical outcomes in acute coronary syndrome patients: results of the ACHILLES Registry;European Journal of Cardiovascular Nursing;2017-05-16

3. Cell-derived microvesicles in cardiovascular diseases and antiplatelet therapy monitoring — A lesson for future trials? Current evidence, recent progresses and perspectives of clinical application;International Journal of Cardiology;2017-01

4. Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients;Thrombosis Research;2016-07

5. Characterization of platelet aggregation responses in microminipigs: Comparison with miniature pigs and the influence of dual antiplatelet administration of aspirin plus prasugrel;Thrombosis Research;2015-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3